Cover Image
市場調查報告書

BioDelivery Sciences International, Inc. - 製品產品管線分析

BioDelivery Sciences International, Inc. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 226253
出版日期 內容資訊 英文 34 Pages
訂單完成後即時交付
價格
Back to Top
BioDelivery Sciences International, Inc. - 製品產品管線分析 BioDelivery Sciences International, Inc. - Product Pipeline Review - 2015
出版日期: 2015年06月24日 內容資訊: 英文 34 Pages
簡介

BioDelivery Sciences International, Inc. 是開發疼痛管理與腫瘍支援療法製品與商品化的專門製藥公司。

本報告針對BioDelivery Sciences International, Inc. 治療藥開發產品管線現況與各開發階段比較分析、藥劑標的、作用程制、用藥方式、分子種類分類治療藥評價、最新企業新聞與發表、後期階段與中止計畫相關情報。

BioDelivery Sciences International, Inc.ソ基本情報

BioDelivery Sciences International, Inc.ソ概要

  • 主要情報
  • 企業情報

BioDelivery Sciences International, Inc.:R&Dソ概要

  • 主要治療範圍

BioDelivery Sciences International, Inc.:產品管線回顧

  • 開發階段分類產品管線製品
  • 單劑製品
  • 併用療法模式
  • 海外授權製品
    • 海外授權製品/併用療法模式

BioDelivery Sciences International, Inc.:產品管線製品概況

  • 最終階段產品管線製品
    • 登錄前製品/併用療法模式
    • 第III期製品/併用療法模式
  • 初期階段產品管線製品
    • IND/CTA Filed Products/Combination Treatment Modalities
  • 前臨床階段製品/併用療法模式

BioDelivery Sciences International, Inc.:藥劑檔案

  • (buprenorphine + naloxone)
  • fentanyl citrate
  • clonidine hydrochloride
  • granisetron
  • BEMA Triptan

BioDelivery Sciences International, Inc.:產品管線分析

  • 標的分類
  • 用藥方式分類
  • 分子種類分類
  • 作用機制分類

BioDelivery Sciences International, Inc.:最近產品管線動向

BioDelivery Sciences International, Inc.:暫停計畫

BioDelivery Sciences International, Inc.:開發中止產品管線製品

  • 開發中止產品管線製品檔案
    • amphotericin B

BioDelivery Sciences International, Inc.:企業發表

BioDelivery Sciences International, Inc.:總公司與分公司所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07239CDB

Summary

Global Markets Direct's, 'BioDelivery Sciences International, Inc. - Product Pipeline Review - 2015', provides an overview of the BioDelivery Sciences International, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of BioDelivery Sciences International, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of BioDelivery Sciences International, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of BioDelivery Sciences International, Inc.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the BioDelivery Sciences International, Inc.'s pipeline products

Reasons to buy

  • Evaluate BioDelivery Sciences International, Inc.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of BioDelivery Sciences International, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the BioDelivery Sciences International, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of BioDelivery Sciences International, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of BioDelivery Sciences International, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of BioDelivery Sciences International, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • BioDelivery Sciences International, Inc. Snapshot
    • BioDelivery Sciences International, Inc. Overview
    • Key Information
    • Key Facts
  • BioDelivery Sciences International, Inc. - Research and Development Overview
    • Key Therapeutic Areas
  • BioDelivery Sciences International, Inc. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Out-Licensed Products
      • Out-Licensed Products/Combination Treatment Modalities
  • BioDelivery Sciences International, Inc. - Pipeline Products Glance
    • BioDelivery Sciences International, Inc. - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • BioDelivery Sciences International, Inc. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • BioDelivery Sciences International, Inc. - Drug Profiles
    • fentanyl citrate
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • clonidine hydrochloride
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BEMA Triptan
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • buprenorphine hydrochloride depot
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • BioDelivery Sciences International, Inc. - Pipeline Analysis
    • BioDelivery Sciences International, Inc. - Pipeline Products by Target
    • BioDelivery Sciences International, Inc. - Pipeline Products by Route of Administration
    • BioDelivery Sciences International, Inc. - Pipeline Products by Molecule Type
    • BioDelivery Sciences International, Inc. - Pipeline Products by Mechanism of Action
  • BioDelivery Sciences International, Inc. - Recent Pipeline Updates
  • BioDelivery Sciences International, Inc. - Company Statement
  • BioDelivery Sciences International, Inc. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • BioDelivery Sciences International, Inc., Key Information
  • BioDelivery Sciences International, Inc., Key Facts
  • BioDelivery Sciences International, Inc. - Pipeline by Indication, 2015
  • BioDelivery Sciences International, Inc. - Pipeline by Stage of Development, 2015
  • BioDelivery Sciences International, Inc. - Monotherapy Products in Pipeline, 2015
  • BioDelivery Sciences International, Inc. - Out-Licensed Products in Pipeline, 2015
  • BioDelivery Sciences International, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015
  • BioDelivery Sciences International, Inc. - Pre-Registration, 2015
  • BioDelivery Sciences International, Inc. - Phase III, 2015
  • BioDelivery Sciences International, Inc. - Preclinical, 2015
  • BioDelivery Sciences International, Inc. - Discovery, 2015
  • BioDelivery Sciences International, Inc. - Pipeline by Target, 2015
  • BioDelivery Sciences International, Inc. - Pipeline by Route of Administration, 2015
  • BioDelivery Sciences International, Inc. - Pipeline by Molecule Type, 2015
  • BioDelivery Sciences International, Inc. - Pipeline Products by Mechanism of Action, 2015
  • BioDelivery Sciences International, Inc. - Recent Pipeline Updates, 2015
  • BioDelivery Sciences International, Inc., Subsidiaries

List of Figures

  • BioDelivery Sciences International, Inc. - Pipeline by Top 10 Indication, 2015
  • BioDelivery Sciences International, Inc. - Pipeline by Stage of Development, 2015
  • BioDelivery Sciences International, Inc. - Monotherapy Products in Pipeline, 2015
  • BioDelivery Sciences International, Inc. - Pipeline by Top 10 Target, 2015
  • BioDelivery Sciences International, Inc. - Pipeline by Top 10 Route of Administration, 2015
  • BioDelivery Sciences International, Inc. - Pipeline by Top 10 Molecule Type, 2015
  • BioDelivery Sciences International, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top